Clinical Trials Directory

Trials / Completed

CompletedNCT03872362

Radiomics Multifactorial Biomarker for Pulmonary Nodules

Radiomics and Clinical Variables Can Differentiate Malignant Nodules and Detect Invasive Adenocarcinoma in Pulmonary Nodules: a Multi-center Study

Status
Completed
Phase
Study type
Observational
Enrollment
800 (actual)
Sponsor
Maastricht University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.

Detailed description

With the development of computed tomography (CT) equipment and the increasing use of lung cancer screening programs with low-dose CT, a growing number of early-stage lung cancers were detected so that a large number of patients have undergone surgery. Although a number of radiological studies have been used morphological signs so-called semantic features to make a differential diagnosis, it is still hard to apply by clinician because pulmonary nodules especially ground-glass nodules and small size nodules have atypical radiology signs and have strong subjectivity from different observers. Recently, CT-based radiomics, extracting the quantitative high-throughput features from medical images and facilitating clinical decision-making system, showed a good performance to predict diagnosis and prognosis of diverse cancer. Therefore, the proposed project aims to develop and validate radiomics models based on CT images to identify malignant nodules and then to discriminate the different types of lung adenocarcinoma in patients with pulmonary nodules.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTradiomicsThe high-throughput extraction of large amounts of quantitative image features from medical images

Timeline

Start date
2018-07-11
Primary completion
2019-01-11
Completion
2019-02-01
First posted
2019-03-13
Last updated
2019-03-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03872362. Inclusion in this directory is not an endorsement.